BioPharma Dive December 9, 2024
Sponsored content By Evaluate
There are plenty of questions about what 2025 might hold for the pharmaceutical market. While uncertainty driven by factors like the Inflation Reduction Act (IRA) have been in play for some time, new questions are being raised almost daily with an incoming Trump administration, the BIOSECURE Act, and an ever-changing geopolitical landscape.
However, there are more predictable realities too, including the continued dominance of obesity and other big diseases, and a need for dealmaking driven by the patent cliff which is no longer looming but well and truly upon us.
Pharma is a long game, so what does the picture look like if we cast an eye out to 2030?
The growth boost
The first...
Today's Sponsors
Today's Sponsor